]>
IRCT20100408003664N22 IRCT 2018-10-07 Tabriz University of Medical Sciences Effect of cinnamon supplementation on antioxidant status in patients with polycystic ovary syndrome Effect of cinnamon supplementation on antioxidant status in patients with polycystic ovary syndrome 2018-10-07 anticipated 84 Complete https://irct.ir/trial/33954 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: Samples were selected using available methods and randomly assigned random blocks of 4 volumes to the study groups.A random sequence is generated using the STATA14 software.During the random assignment, individuals in the groups will be classified according to age and BMI variables, Blinding description: A placebo and supplement will be packed in the same number in similar envelopes. The method of blindness will be that the supplements and placebo will be delivered to the participants by someone other than the researcher, and the researcher will remain unaware until the end of the study. N/A Polycystic Ovarian Syndrome. Intervention 1: Intervention group: 3 capsules of 500 mg cinnamon daily for 8 weeks. Intervention 2: Control group: Plasebo: 3 capsule 500 mg daily, 8 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is The final decision will be taken after the end of the study
public Azam Borzoie
Tabriz University of Medical Science, Nutrition Faculty, Attar Neyshabori, Goldasht street, Tabriz, Iran
tabriz Iran (Islamic Republic of) 5166614711 +41 33357581 s_borzoie@yahoo.com Tabriz University of Medical Sciences scientific Azam Borzoie
Tabriz University of Medical Sience, Nutrition Faculty, Attar Neyshabori, Goldasht street, Tabriz, Iran
tabriz Iran (Islamic Republic of) 5166614711 +98 41 3335 7581 s_borzoie@yahoo.com Tabriz University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: Female:20-38 years old, 25≤BMI>40; At least two standard measurement of amenorrhea or oligomenorrhea; Clinical or laboratory hyperandrogenism and polycystic ovary on ultrasonography . 20 years 38 years Female Exclusion criteria: Thyroid disorders; Hyperprolactinemia, Cushing's syndrome; Liver and kidney diseases; Cardiovascular disease; High blood pressure and diabetes; Pregnant and lactation women; Consumers of anti-obesity and blood lipid-lowering drugs; Anticoagulants and glucocorticoids drugs; Loss wieght diet; smokers; Very active and athletes; Allergic to cinnamon; Seizure and epilepsy disorders ; Cerebrovascular disorders; Individuals undergoing infertility treatments and beta-blockers. E28.2 Polycystic ovarian syndrome Treatment - Drugs Treatment - Drugs Intervention group: 3 capsules of 500 mg cinnamon daily for 8 weeks. Control group: Plasebo: 3 capsule 500 mg daily, 8 weeks Malondialdehyde (MDA). Timepoint: Begining and end of the intervention. Method of measurement: Serum kit. Total antioxidant capacity(TAC). Timepoint: Begining and end of the intervention. Method of measurement: Serum kit. Physical activity. Timepoint: Beginning and end of intervention. Method of measurement: questioner. Diet. Timepoint: Before of Intervention and 8 Weeks After Intervention. Method of measurement: 3-day food record. Tabriz University of Medical Sciences Approved 2018-09-10 Ethics committee of Tabriz University of Medical Science Tabriz University of Medical Science, Nutrition Faculty, Attar Neyshabori, Goldasht street, Tabriz, Iran tabriz East Azarbaijan Iran (Islamic Republic of)